MrC's Smallcap Sweeps for Apr 2022

[MrContrarian]

Smallcap Sweep. 01-Apr-22
Sod this for a laugh

Cohort (CHRT) wins rwo MoD orders for delivery H22022 to mid 2023. One is worth £9m, no value for the 2nd. [SP=441.92 Cap=182m]
Numis (NUM) H1(Mar) trading. Rev down 36% due to weaker Investment Banking. Blames fall in quity capital markets activity across the industry. Outlook: M&A still good but "outlook for capital markets is less certain, however, markets have mostly recovered to levels apparent before the war in Ukraine, which gives us some confidence that market activity will recover to some extent during the second half. Whilst we do not anticipate IPOs to feature prominently in the near term". [SP=260.25 Cap=295m]
CareTech (CTH) PUSU deadline extended. Board minded to recommend 725p indicative offer. [SP=692 Cap=784m]
Peel Hunt (PEEL) guides FY(Mar) rev £131m, ahead of analyst expectations despite the slow-down in activity across global capital markets. Outlook good. [SP=124.1 Cap=152m]
Quiz (QUIZ) guides FY(Mar) rev c. £78m, and pretax £0.5m+, both ahead of expectations (whose?). Outlook good. [SP=10 Cap=12m]
SIMEC Atlantis Energy (SAE) gets non-convertible loan of £2.5m from Scottish Enterprise. Will enable the redeployment of the remaining two turbines at the MeyGen site. [SP=1.56 Cap=11m]
Plant Health Care (PHC) Ager Agro appointed distributor of Harpin αβ product, ProAct in Argentina and Uruguay. Sales to start in Argentina in Q3 2022. [SP=10.75 Cap=33m]
TP Group (TPG) sells Northstar autonomous navigation software for c.£0.6m. [SP=2.44 Cap=19m]
PCF (PCF) temporarily suspended until the publication of the 2021 audited results. [SP=8.7 Cap=22m]
Catenae Innovation (CTEA) suspended pending audited FY. Expects to publish on or around 29 April . [SP=0.29 Cap=1m]
RBG Holdings (RBGP) FY(Dec) and trading sounds in line. [SP=121 Cap=115m]

In line: RNWH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

Note that this is the last free Smallcap Sweep. See https://www.worldgreynews.com/details/2 ... ds-for-ipo


@MrContrarian

[jackdaww]

Smallcap Sweep. 01-Apr-22
Sod this for a laugh

Cohort (CHRT) wins rwo MoD orders for delivery H22022 to mid 2023. One is worth £9m, no value for the 2nd. [SP=441.92 Cap=182m]
Numis (NUM) H1(Mar) trading. Rev down 36% due to weaker Investment Banking. Blames fall in quity capital markets activity across the industry. Outlook: M&A still good but "outlook for capital markets is less certain, however, markets have mostly recovered to levels apparent before the war in Ukraine, which gives us some confidence that market activity will recover to some extent during the second half. Whilst we do not anticipate IPOs to feature prominently in the near term". [SP=260.25 Cap=295m]
CareTech (CTH) PUSU deadline extended. Board minded to recommend 725p indicative offer. [SP=692 Cap=784m]
Peel Hunt (PEEL) guides FY(Mar) rev £131m, ahead of analyst expectations despite the slow-down in activity across global capital markets. Outlook good. [SP=124.1 Cap=152m]
Quiz (QUIZ) guides FY(Mar) rev c. £78m, and pretax £0.5m+, both ahead of expectations (whose?). Outlook good. [SP=10 Cap=12m]
SIMEC Atlantis Energy (SAE) gets non-convertible loan of £2.5m from Scottish Enterprise. Will enable the redeployment of the remaining two turbines at the MeyGen site. [SP=1.56 Cap=11m]
Plant Health Care (PHC) Ager Agro appointed distributor of Harpin αβ product, ProAct in Argentina and Uruguay. Sales to start in Argentina in Q3 2022. [SP=10.75 Cap=33m]
TP Group (TPG) sells Northstar autonomous navigation software for c.£0.6m. [SP=2.44 Cap=19m]
PCF (PCF) temporarily suspended until the publication of the 2021 audited results. [SP=8.7 Cap=22m]
Catenae Innovation (CTEA) suspended pending audited FY. Expects to publish on or around 29 April . [SP=0.29 Cap=1m]
RBG Holdings (RBGP) FY(Dec) and trading sounds in line. [SP=121 Cap=115m]

In line: RNWH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

Note that this is the last free Smallcap Sweep. See https://www.worldgreynews.com/details/2 ... ds-for-ipo


@MrContrarian

===================================

thank god .

[torata]

Smallcap Sweep. 01-Apr-22
Sod this for a laugh

Cohort (CHRT) wins rwo MoD orders for delivery H22022 to mid 2023. One is worth £9m, no value for the 2nd. [SP=441.92 Cap=182m]
Numis (NUM) H1(Mar) trading. Rev down 36% due to weaker Investment Banking. Blames fall in quity capital markets activity across the industry. Outlook: M&A still good but "outlook for capital markets is less certain, however, markets have mostly recovered to levels apparent before the war in Ukraine, which gives us some confidence that market activity will recover to some extent during the second half. Whilst we do not anticipate IPOs to feature prominently in the near term". [SP=260.25 Cap=295m]
CareTech (CTH) PUSU deadline extended. Board minded to recommend 725p indicative offer. [SP=692 Cap=784m]
Peel Hunt (PEEL) guides FY(Mar) rev £131m, ahead of analyst expectations despite the slow-down in activity across global capital markets. Outlook good. [SP=124.1 Cap=152m]
Quiz (QUIZ) guides FY(Mar) rev c. £78m, and pretax £0.5m+, both ahead of expectations (whose?). Outlook good. [SP=10 Cap=12m]
SIMEC Atlantis Energy (SAE) gets non-convertible loan of £2.5m from Scottish Enterprise. Will enable the redeployment of the remaining two turbines at the MeyGen site. [SP=1.56 Cap=11m]
Plant Health Care (PHC) Ager Agro appointed distributor of Harpin αβ product, ProAct in Argentina and Uruguay. Sales to start in Argentina in Q3 2022. [SP=10.75 Cap=33m]
TP Group (TPG) sells Northstar autonomous navigation software for c.£0.6m. [SP=2.44 Cap=19m]
PCF (PCF) temporarily suspended until the publication of the 2021 audited results. [SP=8.7 Cap=22m]
Catenae Innovation (CTEA) suspended pending audited FY. Expects to publish on or around 29 April . [SP=0.29 Cap=1m]
RBG Holdings (RBGP) FY(Dec) and trading sounds in line. [SP=121 Cap=115m]

In line: RNWH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

Note that this is the last free Smallcap Sweep. See https://www.worldgreynews.com/details/2 ... ds-for-ipo


@MrContrarian

===================================

thank god .

Can I ask the mods to change the title therefore to:
MrC's Smallcap Swept

torata

[MrContrarian]

Smallcap Sweep. 04-Apr-22
A catylitic converter for word pollution

Diurnal (DNL) CEO scarpers "to pursue other business opportunities". He is thanked. [SP=16 Cap=27m]
XLMedia (XLM) CEO will leave after a handover. He is thanked. [SP=40.25 Cap=106m]
Likewise (LIKE) first 3 months in line. "In the immediate term, Likewise believes it has the supplier and customer relationships, combined with excellent management and staff, to continue to outperform the marketplace." Intends to commence a progressive dividend policy. [SP=36.75 Cap=89m]
Velocys (VLS) ops update. Expecting US Congress "to pass favourable legislation including the provision of a SAF Producer Tax Credit, indexed to the carbon intensity of the fuel, in the summer which will allow for the launch of the Series A fundraise for Bayou Fuels in H2". [SP=6.2 Cap=88m]
Fulham Shore (FUL) guides FY(Mar) comfortably ahead of market expectations of rev £73.4m, EBITDA £16.5m and adj EBITDA £9.5m. [SP=15.01 Cap=98m]
Zoo Digital (ZOO) launches Nordic hub in Denmark. [SP=122.14 Cap=106m]
HydrogenOne (HGEN) £21.5m placing at 100p, a 9% discount (which it cheekily describes as 'an attractive discount'), to "satisfy short term institutional market demand for shares". So much demand that a 9% discount is required! [SP=109 Cap=NA]
Kromek (KMK) 4 year £1.7m contract for Chemical, Biological, Radiological, and Nuclear detection products and services. [SP=10.03 Cap=44m]
Thruvision (THRU) guides FY(Mar) rev £8.4m, up 25%. Cites very strong Full year Profit Protection revenue. FD leaving this month. He is thanked. Outlook confident. [SP=27.2 Cap=40m]
H&T (HAT) FCA finds that c.9800 high-cost short term loans during 2014-19 should not have been granted. This represents 11.5% of HCST loans. Redress of £2.1m will be paid. This is the fig already allowed for in accounts. Co no longer makes High cost short term unsecured loans. [SP=338.95 Cap=135m]
Induction Healthcare (INHC) four London NHS Trusts sign with Induction Zesty, a digital front door for hospitals. Worth £3.6m over 9 years. £450k will be in FY23. [SP=40.75 Cap=37m]

In line: ECK
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 05-Apr-22
Lobbing hand-grenades at hopeless guff

Beeks Financial Cloud (BKS) £15m placing at 155p, a 3% discount, [SP=174.2 Cap=98m]
MGC Pharmaceuticals (MXC) Sciensus Rare becomes distributor of CannEpil and CogniCann in the EU and UK. Drugs are cannabinoid products for the treatment of Refractory Epilepsy, and Dementia and Alzheimer's. [SP=1.25 Cap=52m]
Faron Pharmaceuticals (FARN) closing Phase II/III HIBISCUS trial assessing Traumakine as a first-line treatment for hospitalised COVID-19 patients. Blames low COVID hospitalization rates. "We expect ongoing Traumakine development efforts will be supported by both academic and industry collaborations." [SP=229 Cap=122m]
Go-Ahead Group (GOG) Conclusions of Business Review: reinstate paying divs of 50% to 75% of underlying EPS; performance improvement program; grow rev; progress new opportunities by "leveraging existing capabilities and resources". Like I leverage my kettle to make extra tea. Targets 30% higher rev in the medium-term and op profit £150m+. [SP=845.56 Cap=365m]
TheWorks (WRKS) has been hacked with "some limited disruption to trading and business operations, including the closure of some stores due to till issues. Replenishment deliveries to the Group's stores were suspended temporarily and the normal delivery window for the fulfilment of online orders was extended, but store deliveries are expected to resume imminently and the normal online service levels are progressively being reintroduced. The Company does not currently anticipate that this incident will have a material adverse impact on its forecasts or financial position...Whilst payment data has not been compromised, it has not yet been possible to establish the full extent to which any other data may have been affected". [SP=52.6 Cap=33m]
Gooch & Housego (GHH) warns FY(Sep) rev up to £2.5m below mgmt exp due to covid affecting H1 output. [SP=1020 Cap=255m]
CyanConnode (CYAN) cellular hub order for a smart metering deployment in MENA Region (Middle East and North Africa), a new territory for the company. No £££. [SP=16.45 Cap=39m]
WANdisco (WAND) $630k contract from larger insurance co to automate the migration of IoT data to multiple cloud providers. Potential to grow beyond the initial agreement. [SP=298 Cap=179m]
Intercede (IGP) guides FY(Mar) rev down 9%, lower than market expectations. Blames delays in new opportunities that had been expected to close this year. Wins $0.3m contract. [SP=58 Cap=33m]
CML Microsystems (CML) guides FY(Mar) slightly ahead of market expectations. Outlook confident. [SP=339.9 Cap=56m]
Glantus (GLAN) new partnership with TealBook to enable customers of both parties to access robust supplier information and insights and stronger AP intelligence. [SP=75.5 Cap=28m]
AdvancedAdvT (ADVT) unsuspended following the publication of the Prospectus on 31 March. [SP=98.49 Cap=131m]
Osirium Technologies (OSI) Q1 trading: continued growth in contract values and a return to pre-pandemic levels. "I am delighted with our performance to date and, given this new business momentum coupled with continued contract renewals, the Board has increasing confidence in the full year." [SP=6.49 Cap=3m]

In line: SRT, IOM, WIN, SDY
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 06-Apr-22
The first train of the trading day

Hyve (HYVE) guides H1(Mat) rec c.£58m (£5m) excluding Russian revenues of c. £17m (£5m). In line? Forward bookings c. £103m excluding bookings for Russian and Ukrainian events. Sells Russian business for £72m max as a 10yr earn-out. Good luck with that. Will retain c.£10m from that biz. [SP=75.21 Cap=219m]
Inland Homes (INL) Group MD Gary Skinner's employment terminated with immediate effect. He is not thanked. [SP=44.35 Cap=101m]
WANdisco (WAND) $720k order from a top 10 global retailer . [SP=299 Cap=179m]
Avon Protection (AVON) guides FY(Sep) U/L profit lower than previously expected. H1(Mar) rev up 4% (in line) but EBITDA margin only c.10% due to additional manufacturing costs, notably in the helmets business, due to supply chain and process inefficiencies. Outlook: "a notable increase in customer enquiry activity.". Board expects EBITDA margins to recover progressively through H2. [SP=1322 Cap=402m]
Gaming Realms (GMR) launches content in Ontario as expected. [SP=31.5 Cap=92m]
Braveheart Investment (BRH) £215k placing (seriously?) at 15p (9% discount) "to continue to support the Strategic Investments..and for working capital". [SP=16.25 Cap=8m]
MJ Gleeson (GLE) comments on industry pledge to fund mitigation works to address life-critical fire-safety issues on buildings over 11m tall. That's 15 buildings and co is not aware of any material fire-safety issues in them but will make further assessment. [SP=584 Cap=341m]
Motorpoint (MOTR) guides FY(Mar) rev up c.82%. Expects op profit and pretax in line with mgmt expectations. Mkt share 3% up 400bp. Outlook "expect rising inflation will place further pressure on discretionary spending power and consumer sentiment". [SP=270 Cap=244m]
Palace Capital (PCA) guides FY(Mar) guides EPRA earnings and adj pretax ahead of market expectations. Final div 3.75p min making FY 13.25p min. [SP=271 Cap=125m]
Distil (DIS) guides Q4(Mar) vol up 38% and rev up 32%. In line? [SP=1.3 Cap=9m]
Sosandar (SOS) guides FY(Mar) rev (up 138%) and EBITDA ahead of recently upgraded market expectations of £27.1m and -£0.9m. Extends deal with Next to sell via Next's 'Platform Plus'. Also wholesale deal with The Very Group. [SP=23.55 Cap=52m]
Avacta (AVCT) FY(Dec) rev £2.9m (£2.1m) and pretax -£29.1m (-£18.9m). Outlook "We are confident and excited about the immediate and long-term future prospects of the Group, with both potential near-term value drivers relating to AVA6000's clinical trial progress, a pipeline of IVD products and a redeveloped SARS-CoV-2 antigen test offering immediate and long-term opportunities." [SP=64 Cap=163m]

In line: GTC, FDP
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 07-Apr-22
Empowering and overpowering BS from ULS

ULS Technology (ULS) to change name to Smoove, a "refreshed, refocused and empowering brand". FFS! Website will be hellosmoove.com. They didn't even get smoove.com! Don't know if the group name will change. [SP=70 Cap=45m]
AdEPT Technology (ADT) guides FY(Mar) rev and adjusted EBITDA only broadly in line with market forecasts. No numbers. Strategic Review - no major change. Will focus on organic growth and reducing gearing. [SP=169 Cap=42m]
Belluscura (BELL) X-PLOR portable oxygen concentrator awarded a Distribution and Pricing Agreement code from the U.S. Defense Logistics Agency. It opens up a significant sales opportunity. [SP=110 Cap=126m]
Alpha FMC (AFM) guides FY(Mar) rev and adj EBITDA significantly ahead of market expectations. Cites double digit organic growth and Lionpoint's ongoing strong progress since acquisition. [SP=340 Cap=382m]
Rockwood Realisation (RKW) GM to vote on change to investment strategy from realisation strategy to continuing as a going concern and to make new investments. [SP=1402.8 Cap=36m]
Enteq Technologies (NTQ) guides FY(Mar) rev above expectations (whose?) and adjusted EBITDA in-line. "The SABER system is on-track for commercialisation during 2022, with existing resources in place to complete the remaining phase of the development project." [SP=13.54 Cap=9m]
Bonhill (BONH) CEO scarpers. He is thanked. £1.1m placing and OO at 5.5p, a 19% discount. Guides FY(Dec) rev £16.4m and EBITDA will be break even. EBITDA £0.2m less than guided due to accounting policy change and dab debt. Also impairment charge of £6.1m relating to the Group's US operations. [SP=6.8 Cap=7m]
WANdisco (WAND) $213k order from" a world leading personal computer vendor". [SP=303 Cap=182m]
SEEEN (SEEN) 3 contracts, for "video momentization [sic] technology and YouTube optimisation services". No £££. [SP=14 Cap=7m]
Arden Partners (ARDN) LSE rejects co's application to remain Nomad after its takeover by Ince Group! [SP=18 Cap=5m]
Omega Diagnostics (ODX) guides FY(Mar) rev £12.3m, up 41%. Covid test rev £2.6m but expected to be minimal in future. Still looking to raise additional funds. [SP=5.6 Cap=18m]

In line: AT., ANX, DLAR, ACC, RWA
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[Hallucigenia]

A nice example yesterday from Canadian Overseas Petroleum (COPL) for fans of the "management punching back against scurrilous rumours on the internet" genre :

Market Clarification
wishes to reiterate its objectives for the 2022 year and address unfounded market rumours, through disinformation posted on social media and internet chat forums, with respect to its annual filings at December 31, 2021...2021 has been a transformative year for the Company and we look to the future with renewed confidence. You will never hear this from "snake oil salesmen" dressed up as experts, commentors or prophets on our Company's business on social media or internet chat platforms due to their sole focus for their own nefarious personal gain.

[MrContrarian]

Smallcap Sweep. 08-Apr-22
Picking the jokers out of the deck of news

Journeo (JNEO) £9m 3 yr framework agreement with First Bus UK for EDGE vehicle gateway and cloud SaaS portal for the tracking, video management and remote condition monitoring of on-vehicle systems. [SP=108.24 Cap=9m]
Sensyne Health (SENS) CEO scarpers. He is thanked. Non-binding term sheet with Noteholders to provide up to £15m in additional converetible loan notes. Believes financing will proceed to completion shortly. Co will prob be insolvent in a month otherwise. Still talks with a small number of parties re sale of co. [SP=9.98 Cap=17m]
Oncimmune (ONC) wins 2 ImmunoINSIGHTS contracts. No £££. [SP=125 Cap=87m]
Avacta (AVCT) AffyXell Therapeutics, a JV with Daewoong Pharmaceutical, enters collaboration with Biocytogen, a Chinese company specialising in developing new biological drugs, and the Korea Non-Clinical Technology Solution Center. Aimed at developing new immune disease in vivo models and carrying out proof-of-concept and toxicity testing of AffyXell's drug candidates using the developed disease models. "The capabilities of the three companies can exert a synergistic effect." Natch'. [SP=89 Cap=226m]
Invinity Energy Systems (IES) successful test and validation program by Korea's Hyosung Heavy Industries of an energy storage system. Signs non-binding MoU for a global partnership with an exclusive relationship in Korea. [SP=80.13 Cap=93m]
Nightcap (NGHT) to open large site in Birmingham. [SP=16.6 Cap=32m]
Webis (WEB) wins 5 yr contract to operate live Harness Racing, pari-mutuel wagering and food and beverage operations at Arizona venue, subject to regulatory approval. No $$$. [SP=2.94 Cap=12m]
Ramsdens (RFX) guides H1(Mar) pretax c. £2m (-£0.1m). In line? "Board is encouraged by the growing demand for Ramsdens' services." [SP=173 Cap=55m]
Foresight (FSG) guides FY(Mar) rev and core EBITDA in line with or slightly ahead of mgmt expectations. [SP=365 Cap=395m]
Vp (VP.) guides FY22 ahead of mgmt expectations. Outlook: "We are encouraged by the improvement in sentiment and performance experienced in the final quarter." [SP=870 Cap=349m]
Smoove (SMV) name change from ULS Technology. [SP=NA Cap=NA]
Hollywood Bowl (BOWL) guides FY(Sep) ahead of market expectations after strong H1. Intends to resume divs. "Although not immune from inflationary pressures, centre level labour accounts for less than 20 per cent of sales and the Group has taken a number of mitigating actions including maintaining a simplified food menu...The main potential exposure is energy costs, which the Group has hedged out to the end of FY2024." [SP=261.5 Cap=447m]
Physiomics (PYC) wins contract for "specialist mathematical modelling services using its Virtual Tumour software platform to model and simulate the effect of a number of immuno-oncology combinations". To complete over next 7-8 months. [SP=4.67 Cap=5m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 11-Apr-22
18 summaries today.

Lamprell (LAM) MoU with NOV, a leading energy services company, to support its delivery of three 1 gigawatt offshore floating wind farms. No £££. [SP=25.27 Cap=104m]
Immotion (IMMO) Q1 rev £2m (£0.8m). Guides FY(Dec) rev £9.4m and EBITDA c.£0.9m [SP=4.7 Cap=19m]
Arden Partners (ARDN) Ince waives nomad condition of its takeover. [SP=13 Cap=4m]
Cellular Goods (CBX) responds to FSA not having its ingestibles products on its new approved list of CBD products. It "is not necessary in order for the products to remain on the market. The Company fulfils FSA guidance as this is not a 'new product' to market and all the FSA required details are clearly stated on the labelling such as product name (Pureis), legal address, product code and supplier which is the same as that of the validated CMH products featured on the FSA list." [SP=3.2 Cap=16m]
Cordel (CRDL) Q3 rev up 114%. "Our third quarter saw a return to the growth trajectory anticipated in our plan, as revenue from major contracts began to flow. We have confidence in a continued strong performance during the remainder of the year and beyond." The RNS wrongly gives the ticker as MNO which changed in Nov. [SP=9.7 Cap=16m]
Harland & Wolff (HARL) contract win from P&O Cruises and Cunard for dry docking two cruise vessels. 33 days total. No £££. [SP=21.67 Cap=35m]
Nightcap (NGHT) tp open a Tonight Josephine brand bar in Liverpool later this year. Didn't Napoleon say "Not tonight Josephone"? I guess she didn't take him to a cocktail bar. [SP=19 Cap=36m]
WANdisco (WAND) Q1 bookings $5.8m( $1.1m). "The high visibility of WANdisco's near term business pipeline underpins confidence in continued strong trading in 2022." [SP=288 Cap=173m]
Marks Electrical (MRK) Q4 rev up 19%. In line? Expects FY adj EBITDA margin target 9%, in line with market expectations. [SP=94.9 Cap=100m]
Manolete (MANO) guides FY(Mar) EBIT £5-6m, below mkt expectations. Blames covid. "There is expected to be an insolvency 'catch up' effect over the next 12 months and beyond which will provide Manolete with significantly increased opportunities. Just completed one of its larger case investments for £9.5m yielding c.£5.6m for MANO. [SP=230 Cap=99m]
React (REAT) wins 3 yr £0.7m regular facilities maintenance cleaning contract. [SP=1.72 Cap=9m]
Induction Healthcare (INHC) NHS England contract renewals secure £6.6m ARR. Retention rate significantly above management expectations. [SP=42.4 Cap=40m]
STM (STM) its appeal in the long-standing Adams v Carey case has been declined. This "does not directly impact STM's exposure in this case, but it will have implications for the Financial Services industry more broadly." [SP=29 Cap=17m]
Duke Royalty (DUKE) guides Q1 FY23 normalised cash revenue £5m, up £0.3m QoQ. [SP=40.5 Cap=143m]
Audioboom (BOOM) Q1 revenue $19.7m, up 107%. Adj EBITDA $0.9m ($0.03). [SP=2000 Cap=324m]
Avingtrans (AVG) two new nuclear contracts in S Korea, worth $7m total, to be completed before June 2023. [SP=451.11 Cap=149m]
Mothercare (MTC) guides FY(Mar) rev £385m. Adj EBITDA £11.5-12m, ahead of analysts’ expectations. Pension deficit £66m (March 2020: £124.6m). Outlook: cost-cutting by partners "likely to mean that the return to pre pandemic levels of trading may take longer and in some cases we may directly contribute to achieve that recovery." [SP=10.1 Cap=61m]

In line: TET
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 12-Apr-22
Poor MEAL deal for shareholders. WINK in the pink.

Go-Ahead (GOG) FRC will investigate audits for FY16 to FY21. [SP=840.81 Cap=363m]
Novacyt (NCYT) second direct-to-PCR COVID-19 test gets UK approval. It "removes the need for complex, manual, or automated extraction solutions to significantly improve laboratory workflow and reduce costs." [SP=227.43 Cap=194m]
Supreme (SUP) guides FY(Mar) rev over £130m up 6.6% and adj EBITDA £21m+ up 9%. In line? FY23 profit "will be tempered by commodity price inflation within Sports Nutrition & Wellness and the increases in the overhead base relating to wage and transport costs". [SP=189.5 Cap=221m]
Argentex (AGFX) guides FY(Mar) rev up 23% and U/L op profit margins broadly in line with prior year (30.9%). In line? [SP=78.8 Cap=89m]
Feedback (FDBK) wins two twelve-month contracts worth £200k total for Bleepa. [SP=0.68 Cap=18m]
Warpaint London (W7L) positive momentum has continued in Q1 with rev up c.60%. Gross product margin up despite increased costs in the supply chain. [SP=140 Cap=107m]
Impellam (IPEL) majority shareholder, Lord Ashcroft intends to sell and "open discussions with the Board in order to explore the various options for implementing this sale". Co therefore up for sale. [SP=420 Cap=190m]
Hornby (HRN) Q4(Mar) rev in line and will make a profit. Bemoans "extended shipping times from our partner factories and disruptions in UK deliveries into our warehouse due to a lack of drivers and fuel. Electronic components availability and lead times have also impacted our ability to increase sales further in FY22". [SP=34.5 Cap=58m]
e-Therapeutics (ETX) hits key milestone in Galapagos collaboration and gets a cash payment. Co "is eligible to receive additional milestone payments through pre-clinical and clinical development, regulatory as well as commercial milestones". [SP=27.31 Cap=141m]
Parsley Box (MEAL) FY21 in line ie a dismal increase in sales of 5% and a £9.7m loss. Outlook "Stock levels have continued to increase since the year end and more than 95% of product lines are now available...progressing well towards its FY22 target of 25% growth in repeat AOV...fresh targeted marketing strategy...showing early positive signs of acquiring higher spending customers. Whilst marketing expense was reduced in Q1 by c.50% of FY21 average to test the new strategy, higher levels of marketing spend has resumed from April." [SP=20.88 Cap=15m]
Winkworth (WINK) FY(Dec). Outlook "increasing interest in central London markets, where both sales and lettings are benefiting as city life returns to a more normal footing, we expect activity to be brisk...In the country markets, it is possible that activity will drop off from the elevated levels experienced in 2021, but a shortage of supply should continue to support prices in the near term...Rental demand remains very strong." [SP=190 Cap=24m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 13-Apr-22
CBD, FSA, NFT, PUSU, ARR, WTF and many more

Cellular Goods (CBX) rows back on its claim that its ingestibles product range can still be sold in UK following their omission from FSA list.. Co "is considering its position pending advice from the company's advisers and is also seeking further clarification on the FSA's stance, considering that these products are identical to the validated products from CMH." [SP=2.75 Cap=14m]
Ocean Outdoor (OOUT) confirms bid rumour. It's in discussions with Atairos regarding a possible offer. [SP=9 Cap=484m]
Ted Baker (TED) Sycamore Partners released from PUSU deadline of 15 Apr. No certainty that an offer will be made. [SP=148.4 Cap=274m]
Shearwater (SWG) wins 3 yr £12.9m contract with option to extend worth c.£8m. [SP=109.5 Cap=26m]
Avacta (AVCT) milestone equity payment triggered resulting in an increase shareholding in AffyXell Therapeutics JV. Avacta has developed and characterised Affimer proteins against the first target for AffyXell. [SP=112 Cap=285m]
Billington (BILN) guides FY(Dec) slightly ahead of market expectations. Post yr end makes provision of c.£1.1m due to contractor client going bust. [SP=233 Cap=30m]
MaxCyte (MXCT) CFO scarpers on 15th but will provide consulting services for handover. She is thanked. Guides Q1 rev $11m ($6.5m). [SP=440 Cap=443m]
itim (ITIM) three new customer wins and extensions of existing contracts hikes ARR by £1.8m. [SP=106 Cap=33m]
Mobile Streams (MOS) contract with Fanzine Limited to become their exclusive producer of Non-Fungible Tokens. Fanzine currently operates 41 club-specific premium domains. [SP=0.3 Cap=10m]
Steppe Cement (STCM) Q1 vol up 6%, rev up 29%. Co expects "Kazakhstan's cement market demand will remain at 11 to 12 million tonnes but there is a high degree of uncertainty regarding this due to the geopolitical situation." [SP=31.5 Cap=69m]

In line: WJG
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 14-Apr-22
Taking down notes, taking up cudgels

Tungsten (TUNG) takeover Scheme Document delayed to 25 Apr. Blames Court spring recess. [SP=45.5 Cap=58m]
Porvair (PRV) AGM stmt: lasr 4 months rev up 14%, organic (at const FX) up 10%. "Near-term supply dislocations and inflationary pressures continue but the Group has avoided major problems thus far. Order books are in some cases flattered by extended lead times, but looked at on an underlying basis remain healthy." [SP=628 Cap=290m]
Renold (RNO) guides FY(Mar) underlying trading profit materially ahead of expectations. Cites stronger sales, benefits of cost reduction and efficiency programmes, and implementation of price increases. [SP=20.1 Cap=45m]
Softline (SFTL) $1 tender offer for 10% of capital. [SP=NA Cap=NA]
React (REAT) £5,5m placing at 1.2p, a poke-in-the-eye 33% discount, for acquisitions. So it has bumped up effective price of acquisitions by 50%. [SP=1.7 Cap=9m]
HeiQ (HEIQ) guides FY(Dec) rev up 15%, ahead of market guidance but post-tax of only $2.7m. Auditors force co to defer certain revenues related to technology milestones with The Lycra Company - hits op profit by $1m. Higher raw materials and logistics costs continued in H2. Guides FY22 rev up 20%. [SP=75.32 Cap=99m]
CareTech (CTH) possible offer price hiked to 750p from 710p. Directors would be minded to recommend. [SP=750 Cap=850m]
Norcros (NXR) guides FY(Mar) U/L op profit ahead of its previous expectations. Rev up 22% and 16% on FY20. Pension deficit (2021) £35.8m (2018: £49.3m).Deficit repair contributions will be £3.8m PA. [SP=240 Cap=195m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 19-Apr-22
Wedded to safety but flirting with danger

Woodbois (WBI) Q1 rev up 22%. Gross margin 23% (20%). Absent any further material disruption to the shipping routes and container availability we plan to deliver strong quarter-on-quarter growth throughout the remainder of the year." [SP=4.45 Cap=109m]
Velocys (VLS) further to 4 Apr RNS, has entered into a contract with a European renewable fuels developer to provide initial engineering services to a project, which is in the planning stages. Negligible rev but "broadens the Company's customer base and demonstrates the ability to progress its pipeline of potential global customers towards commercial contracts." [SP=6 Cap=84m]
IDE (IDE) £1m loan from MXC converted into same terms as the existing loan notes. MXC has begun exploratory conversations re converting its loan notes into equity. [SP=1.17 Cap=6m]
Chill Brands (CHLL) internal promotion to CEO. Antonio Russo and Trevor Taylor, currently Co-Chief Executive Officers, will assume other senior roles. They are thanked. [SP=5.06 Cap=10m]
Sensyne Health (SENS) in light recently the amended financing terms co ends Formal Sale Process. Plans to delist. New CEO. [SP=1.84 Cap=3m]
Iofina (IOF) iodine spot prices $60/kg and above, up 20% YTD. Production in line. Close to finalising an agreement for the construction of IO#9 with a new brine supply partner. Working on enhancements to improve efficiencies and increase capacities for certain iodine and non-iodine products. [SP=19.65 Cap=37m]
Ideagen (IDEA) notes announcement made by Cinven re possible offer. Co has not received an approach yet. [SP=253 Cap=743m]
Microsaic Systems (MSYS) new framework agreement and initial contract worth £400k from Innovenn UK, a division of DeepVerge. This formalises existing framework agreement. [SP=0.1 Cap=7m]
D4T4 Solutions (D4T4) guides FY(Mar) rev in line and adj pretax at the upper end of market expectations. ARR up 32%. We expect to announce further contract wins in the coming months. [SP=235.26 Cap=95m]
Venture Life (VLG) delays FY results to early May. Says "auditors continue to experience resourcing issues". Reiterates its guidance. [SP=36.9 Cap=46m]
Stanley Gibbons (SGI) guides FY(Mar) rev £12m. Cites reduced impact of COVID related restrictions. "After a much reduced catalogue production schedule in recent years, the Publishing division is once again regularly producing stamp catalogues. Combined with increased efficiency in this part of the business, market share gains in magazines and further progress on the digital product side, we expect to see continued improvement in performance here." Majority holder once again formally waived the loan covenants which we are in default. [SP=2.2 Cap=9m]

In line: SYS, CBOX, CER
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 20-Apr-22
Failhouse crock

Intosol (INTO) the luxury travel company heading for the ditch as it discusses continued funding from insiders which may or not include delisting. 95% down on IPO. [SP=5 Cap=1m]
Coral Products (CRU) guides FY(Apr) rev and pretax materially above market expectations. Pretax boosted by sale of land and building at Haydock. Second interim dividend of 0.4p. [SP=15 Cap=12m]
Cornerstone FS (CSFS) Q1 rev £946k, a new high. Organic rev £888k, above all of previous H1. [SP=17.1 Cap=4m]
Bonhill (BONH) £1.74m placing and OO at 5.5p, a nil discount, to keep the lights on. FY(Dec) in line. Q1'22 rev up 10%. [SP=5.7 Cap=6m]
Diurnal (DNL) adds Alkindi and Efmody to its distribution agreement with Er-Kim for Greece, Cyprus and Malta, targeting a market opportunity of c. €7m. [SP=15.55 Cap=26m]
Volex (VLX) guides FY(Apr) rev over $605m and U/L op profit over $55m, ahead of market expectations of $581.2m and $54.2m. [SP=244.59 Cap=388m]
Polarean Imaging (POLX) has accepted the resubmission of its New Drug Application for use of using hyperpolarised Xenon to enhance MRI in pulmonary medicine. "We look forward to resuming the review process with them in the expanded context of our response." [SP=55 Cap=117m]
Motorpoint (MOTR) sale and leaseback of Stockton branch for £5m. Further increases its available stocking facility by £30m. [SP=251 Cap=226m]
Seeing Machines (SEE) signs an IP licence agreement for its Occula Neural Processing Unit (for human detection and tracking) with an additional US based semiconductor company. [SP=8 Cap=331m]
Real Good Food (RGD) serves up another warning. Guides FY(Mar) up 9%. Pretax -£2.8m (-£6.1m). Both below mgmt exp. "Trading in Q4 and in the first weeks of our new financial year continued to be impacted by shortages and absences, whilst significant input cost increases have also dragged profitability down." [SP=1.8 Cap=2m]

In line: SFR, ITX, BIOM, SNX, WINE
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 21-Apr-22
The anvil for hard news

Solid State (SOLI) guides FY(Mar) rev £85m up 28% and adj pretax £7.2m up 33%, ahead of consensus expectations of £80m and £6.5m. [SP=1015 Cap=87m]
Real Good Food (RGD) FD resigns after yesterday's warning, leaves Sept. She is thanked. [SP=1.9 Cap=2m]
Capital (CAPD) Q1 rev up 52% but down 1% from prev Q. Keeps FY rev guidance. [SP=105.5 Cap=201m]
MGC Pharmaceuticals (MXC) gets EU patent for Investigational Medical Product, CimetrA. [SP=1.26 Cap=66m]
Gear4music (G4M) another co with a post-lockdown hangover. Guides FY(Mar) rev £147.6m down 6% and EBITDA £11m, both below market expectations (£149.2m and £12m) due to weaker than expected consumer demand during February and March. "Short term inflation-linked overhead cost pressures and weaker consumer confidence...will mean the best opportunities for stronger growth during FY23 are likely to be in H2. We are, accordingly, moderating our overall growth expectations for the new financial year," [SP=359.91 Cap=75m]
LSL Property Services (LSL) £10m max share buyback. [SP=376.9 Cap=396m]
Ibstock (IBST) guides FY22 modestly ahead of mgmt expectations after strong Q1. £30m buyback. [SP=166.4 Cap=682m]
ProCook (PROC) guides FY(Apr) pretax broadly in line with market expectations of £10m. Q4 rev up 11.4%, FY up 30%. Gross margin 140bps lower, in line with mgmt expectations. "Trading conditions have become more challenging over the last quarter." [SP=125 Cap=136m]
Induction Healthcare (INHC) guides FY(Mar) rev and adj EBITDA in line. Will "invest above current expectations in development, delivery and commercial resources. This will not only underpin and de-risk FY23 growth forecasts, but also accelerate both contracted ARR and recognised revenue growth into FY24 and beyond". [SP=57.8 Cap=53m]
NewRiver REIT (NRR) guides FY22 Underlying Funds From Operations at upper end of analysts' estimates of 7p to 8.8p/sh. [SP=86.7 Cap=267m]
Immedia (IME) sells its struggling business to its mgmt for £2m, will become cash shell called Immediate Acquisition, a hostage to fortune surely. Operations remain too small to readily absorb the costs of being a PLC and generate a return for investors. [SP=21.2 Cap=8m]
Rank (RNK) cuts FY(June) EBIT guidance from £55m-£65m to £47m-£55m. "The performance of our venues softened in March, and this has continued into the first few weeks of Q4." [SP=128.4 Cap=601m]
Colefax (CFX) guides FY(Apr) pretax ahead of market expectations. Cites strong Fabric Division sales. "We are experiencing significant inflationary pressures so although demand is currently strong this adds a note of caution to prospects for the year ahead." [SP=630 Cap=50m]
IXICO (IXI) £800k contract for Huntington's Disease trial over 2.5 years. [SP=35.9 Cap=17m]
Brickability (BRCK) guides FY(Mar) rev c.£520m and adjusted EBITDA £38m+, ahead of market expectations. [SP=97 Cap=290m]
Meggitt (MGGT) Q1 rev up 5% organic. "We are pleased with the strengthening of conditions in the quarter. However, the recovery in civil aerospace continues to be uneven." No FY guidance. [SP=770 Cap=6028m]
Seeing Machines (SEE) collaboration with leading automotive systems supplier on Driver Monitoring System demonstrator. [SP=8.1 Cap=336m]

In line: FOXT, DPP
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 22-Apr-22
News lube for smoother investing

Itaconix (ITX) £300k placing at 4.5p, an 11% discount, to strengthen finished goods inventories held in the EU. [SP=5.14 Cap=23m]
Zinc Media (ZIN) FY(Dec). Outlook "The pipeline for the Group is over £35m of potential new business which could deliver in 2022, of which £8m is highly advanced with buyers...Group has every expectation of accelerating the conversion of this strong pipeline as confidence returns to the market, and fully expects to see a faster conversion of new business in the year ahead." [SP=121.7 Cap=20m]
One Media iP Group (OMIP) the delayed FY(Oct). Outlook: no material impact from Russia sanctions. Final div 0.055p. Outlook "Ongoing supportive market backdrop with music industry growth projections accelerating". [SP=6.49 Cap=14m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 25-Apr-22
A hard rap on news knuckles

SpaceandPeople (SAL) FY(Dec) rev £4m, £0.5m less than guided in Feb! Adj EPS-cont 0.9p (-7.2p). Co does not even explain the miss. Outlook "seeing business levels returning and footfall in our venues continuing to grow. This has been helped by the removal of working from home advice and by the phasing out of covid testing". [SP=15 Cap=3m]
AEW UK REIT (AEWU) agrees terms to sell Eastpoint Business Park, Oxford for c. £37m, a significant premium equal to 11p/sh. No guarantee that the transaction will complete. [SP=128.6 Cap=203m]
CentralNic (CNIC) guides FY22 materially above mkt exp after strong Q1. [SP=118.61 Cap=339m]
ZOO Digital (ZOO) guides FY(July) rev c.$70m (up 78% organic) and adj EBITDA c.$8m. Guidance was $65m+ and $6.5m+. [SP=111.93 Cap=99m]
Totally (TLY) guides FY(Mar) EBITDA substantially ahead of market expectation of £5.4m. Cites "enhanced demand attributed to the impact of the global pandemic, which has increased demand for services and led to significant growth in waiting lists". [SP=42.25 Cap=81m]
City of London (CIN) agreed in principle £8m and £9m equity raise through exercise of warrants held by 2 shareholders and a separate subscription. [SP=57.25 Cap=62m]
7digital (7DIG) wins £1m+ 2 yr contract with a pan-Asian consumer services company. [SP=0.28 Cap=7m]
Polarean Imaging (POLX) additional research unit order for a Xenon Polariser. No $$$. [SP=55 Cap=116m]
Yourgene Health (YGEN) extends strategic partnership with Ambry Genetics with a new Genomic Services collaboration to allow both to access to each other's technology and assays, expanding market access and penetration for both. Ambry is the unnamed partner in RNS of 9 June 2021. [SP=9.95 Cap=71m]
Insig AI (INSG) £145k contract from a London based alternative investment manager, to complete by end June. Guides FY(Mar) rev slight beat. Founder Steve Cracknell becomes Chief Product Officer and Chief Commercial Officer becomes CEO. [SP=27 Cap=30m]
Diurnal (DNL) Efmody distribution and marketing agreement signed with EffRx for Switzerland. [SP=14.8 Cap=26m]
McColl's Retail (MCLS) warns FY22 adjusted EBITDA no higher than FY21 (£20m on a pre IFRS 16 basis). Even if it get funding deal it's "increasingly likely to result in little or no value" for ordinary shares". [SP=3.94 Cap=12m]
Bonhill (BONH) £0.6m OO and £0.6m placing at 5.5p, a 5% discount. Trading in line. [SP=6 Cap=5m]

In line: IXI, SED, MIND
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 26-Apr-22
Ironing creases into news releases

Tungsten (TUNG) rival bidder claims it's at "a highly advanced stage, in respect of its preparations for the making of any Possible Offer" of 45p, above the 42p rec offer. [SP=46.79 Cap=57m]
Novacyt (NCYT) Gov't issues a claim of £134.6m, broadly in line with the disputed Q4 2020 revenue, as previously announced. [SP=195 Cap=171m]
Loungers (LGRS) guides FY(Apr) profit slightly ahead of market expectations. LFL Rev up 18% over 2020 including VAT benefit, 9% without. [SP=246 Cap=253m]
Origo Partners (OPP) shares will be suspended on 28 Apr due to Arden losing Nomad approval and cancelled on 20 May. Origo will announce a payout of all distributable cash and will make that payment as soon as practicable thereafter. [SP=0.12 Cap=m]
Elementis (ELM) trading: Q1 cash generation in line. Chromium performance declined due to an unexpected temporary plant outage. Strategic review of its Chromium biz to consider if the "full potential of Chromium can best be delivered as part of Elementis, or, via a full or partial divestment". [SP=121.9 Cap=729m]
Franchise Brands (FRAN) AGM stmt. Sounds in line. [SP=157 Cap=201m]
Yourgene Health (YGEN) guides FY(Mar) rev in line, EBITDA margin broadly in line with 10% guidance on a constant currency basis and before restructuring costs. Outlook: restructuring to focus on post-pandemic growth drivers. [SP=9.9 Cap=72m]
Lords Group Trading (LORD) guides FY(Dec) rev in line with market expectations of £363m and profitability in line with or exceeding market expectations, with adj EBITDA c. £21.5m and adj EPS 5.4p+. Outlook: repairs, maintenance and improvement (RMI) has remained strong, Merchanting division in line. Is RMI not in line then? Heating and Plumbing rev down 12% due to supply chain problems. Overall FY22 rev largely in line and profitability in line. [SP=91.09 Cap=148m]
PCI-PAL (PCIP) guides FY(June) above market expectations. Q4 Net Revenue Retention performance 118%. Update on patent claim. [SP=67.55 Cap=44m]
Manolete Partners (MANO) £5.6m share of case now received. "With new case enquiries rebounding sharply upwards following the challenges of Omicron, we look forward to further strong progress." [SP=235 Cap=100m]
Dillistone (DSG) the part-time CEO to leave after handover. She is thanked. [SP=20.3 Cap=4m]
Toople (TOOP) CFO scarpers. He is not thanked. [SP=0.03 Cap=1m]

In line: SRC, TRAK
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 27-Apr-22
Watching the clowns driving their vehicle over shareholders.

Chill Brands (CHLL) [last night] raises £0.6m at 2p, a 64% discount with attached £2.9m in converts (at 2p strike). It "will provide sufficient working capital for the current financial year". [SP=4.88 Cap=11m]
Supply @ME Capital (SYME) £7.5m max equity (+warrants) instalment plan at 0.05p (39% discount) initially or lower of 0.05p / 15% discount to prevailing. Delays FY21 report to end Apr, I guess to get a going concern stmt through. [SP=NA Cap=NA]
Tandem (TND) CEO gets on his bke, rides out 6 May. He is not thanked. [SP=393 Cap=21m]
IG Design (IRG) guides FY(Mar) rev up 10%. Op margin 0.5% giving operating profit marginally ahead of guidance. Small adj pretax loss but EPS significantly below market expectations due to lower than expected future earnings in the USA leading to a non-cash one-time reversal of deferred tax assets. Expects marginal operating profit improvement in FY23. [SP=NA Cap=NA]
Shearwater (SWG) guides FY(Mar) rev up c.12% and adj EBITDA over £4.2m, both ahead of market expectations. Cites a mix of strong renewals from long term clients in addition to a number of significant new contract wins in the Group's Services division. [SP=132.5 Cap=32m]
LoopUp (LOOP) 2 year contract from Telefonica worth €200k. Cloud Telephony sales in line. [SP=6.97 Cap=7m]
Metro Bank (MTRO) Q1 sounds in line. [SP=86 Cap=148m]
SIMEC Atlantis Energy (SAE) begs £5m lender to defer June repayment and upcoming interest payment. [SP=2.48 Cap=18m]
System1 (SYS1) guides FY(Mar) rev up 6%, adj pretax £1.1m (£3m). "Profitability was stronger in H1 than H2 as the planned increase in H2 operating costs coincided with a reduction in revenue during the final quarter." Outlook: "Having stepped up our investment in people, partnerships and platform to develop and commercialise our automated marketing predictions last year, we are convinced that it is right to keep those resources and infrastructure in place despite the fall off in revenue performance in the last quarter". [SP=272.99 Cap=35m]
Sportech (SPO) 7p capital distribution, xd 5 May. [SP=33 Cap=33m]
Alfa Financial Software (ALFA) Q1 rev up over 10%. 3p special div xd 5 May. [SP=167.38 Cap=501m]
RPS (RPS) Q1 slightly ahead of the Board's expectations, with 12% growth in Fee Revenue and continued margin improvement. [SP=102 Cap=283m]
Ted Baker (TED) re FSP: receives a number of non-binding takeover proposals. [SP=150 Cap=277m]
Inspecs (SPEC) Q1 rev up 12%, 19% at const FX. In line? [SP=330 Cap=338m]
Nichols (NICL) AGM stmt: UK rev up 11% but international down 16% "as shipment timings were severely impacted towards the end of the quarter by national driver industrial action in Spain. The action has now ended". FY adj pretax expectations in line despite cost pressures. [SP=1361 Cap=496m]
4basebio (4BB) Joint Development Agreement with Heqet Therapeutics focussed on the development of a non-viral vector. [SP=501 Cap=62m]

In line: PDG, IGE
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian